Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
260 participants
OBSERVATIONAL
2021-07-13
2029-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medtronic Cardiac Surgery PMCF Registry
NCT04073420
Trifecta™ GT Post Market Clinical Follow-up
NCT03016169
NVT ALLEGRA TAVI System TF in Failing Surgical Aortic Bioprosthesis
NCT03287856
Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease
NCT06737757
Elimination of Microemboli During Aortic Valve Replacement
NCT01128751
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
VAVGJ
VAVGJ
Replacement of the aortic valve and ascending aorta
Group 2
CAVGJ
CAVGJ
Replacement of the aortic valve and ascending aorta
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VAVGJ
Replacement of the aortic valve and ascending aorta
CAVGJ
Replacement of the aortic valve and ascending aorta
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* active endocarditis
* anatomical or medical, surgical, psychological or social contraindications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital - Univ. of Alabama at Birmingham (UAB)
Birmingham, Alabama, United States
University of Michigan
Ann Arbor, Michigan, United States
Mission Health & Hospitals
Asheville, North Carolina, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Klinik Floridsdorf
Vienna, , Austria
Rigshospitalet
Copenhagen, , Denmark
CHU de Besancon - Jean Minjoz
Besançon, , France
CHRU Lille
Lille, , France
Groupe Hospitalier Bichat - Claude Bernard
Paris, , France
Herz-und Diabetes Zentrum NRW
Bad Oeynhausen, , Germany
Deutsches Herzzentrum Berlin
Berlin, , Germany
Klinikum Links der Weser
Bremen, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
Onassis Cardiac Surgery Center
Athens, , Greece
Policlinico S.Orsola-Malpighi
Bologna, , Italy
Ospedale San Raffaele
Milan, , Italy
Policlinico San Donato
San Donato Milanese, , Italy
Wojewodzki Szpital Zespolony w Kielcach
Kielce, , Poland
Krakowski Szpital Specjalistyczny im. Jana Pawla II
Krakow, , Poland
Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi
Lodz, , Poland
The Cardinal Stefan Wyszynski Institute of Cardiology
Warsaw, , Poland
Hospital Universitario del Vinalopó
Elche, , Spain
Hospital Universitario Son Espases
Palma de Mallorca, , Spain
James Cook University Hospital
Middlesbrough, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABT-CIP-10386
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.